Entrada's mission is to treat devastating diseases with intracellular biologics

"At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments."

Dipal Doshi, President and Chief Executive Officer

Novel Platform, Growing Intracellular Biologics Pipeline

Entrada’s Endosomal Escape Vehicle (EEV™) technology represents a fundamental advancement to the design and development of intracellular biologics. Our therapeutic candidates exhibit high cellular uptake, achieve highly efficient endosomal escape and are designed to be exquisitely specific to intracellular targets.

Our novel approach addresses challenges associated with current therapeutics and allows us to engage targets previously considered inaccessible and undruggable. Explore our platform and discover our pipeline.